Venlafaxine Hydrochloride Tablet
FDA Label NDC 65841-674

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Venlafaxine Hydrochloride (NDC 65841-674). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-671-01 in bottle of 100 Tablets

Venlafaxine Hydrochloride Tablets, 25 mg

Rx only

100 TABLETS

 

Venlafaxine Tablets Usp, 25 mg (Bc985772 E546 450c B47f 20dce221c69d 02)

Venlafaxine Tablets Usp, 25 mg (Bc985772 E546 450c B47f 20dce221c69d 02)

NDC 65841-672-01 in bottle of 100 Tablets

Venlafaxine Hydrochloride Tablets, 37.5 mg

Rx only

100 TABLETS

 

Venlafaxine Tablets Usp, 37.5 mg (Bc985772 E546 450c B47f 20dce221c69d 03)

Venlafaxine Tablets Usp, 37.5 mg (Bc985772 E546 450c B47f 20dce221c69d 03)

NDC 65841-673-01 in bottle of 100 Tablets

Venlafaxine Hydrochloride Tablets, 50 mg

Rx only

100 TABLETS

Venlafaxine Tablets Usp, 50 mg (Bc985772 E546 450c B47f 20dce221c69d 04)

Venlafaxine Tablets Usp, 50 mg (Bc985772 E546 450c B47f 20dce221c69d 04)

NDC 65841-674-01 in bottle of 100 Tablets

Venlafaxine Hydrochloride Tablets, 75 mg

Rx only

100 TABLETS

Venlafaxine Tablets Usp, 75 mg (Bc985772 E546 450c B47f 20dce221c69d 05)

Venlafaxine Tablets Usp, 75 mg (Bc985772 E546 450c B47f 20dce221c69d 05)

NDC 65841-675-01 in bottle of 100 Tablets

Venlafaxine Hydrochloride Tablets, 100 mg

Rx only

100 TABLETS

Venlafaxine Tablets Usp, 100 mg (Bc985772 E546 450c B47f 20dce221c69d 06)

Venlafaxine Tablets Usp, 100 mg (Bc985772 E546 450c B47f 20dce221c69d 06)

* Please review the disclaimer below.